Laura A Williams Insider Profile
11 Followers
Laura A Williams, Chief Patient Officer at Ardelyx, holds 367.46K shares in Ardelyx (Ticker: ARDX), holds ― shares in Enliven Therapeutics (Ticker: ELVN). Most recently, Laura A Williams Sold ― shares of Ardelyx on Aug 25, 2026 for an estimated value of $41.35K.
Laura A Williams Ardelyx (ARDX)Chief Patient Officer
Ardelyx (ARDX)
Chief Patient Officer
Ranked #102,813 out of 108,921 Corporate Insiders
Profitable Transactions
8 out of 17 Profitable Transactions
Average Return
-30.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Laura A Williams holds in companies
Most Profitable Insider Trade
The most profitable trade made by Laura A Williams
Laura A Williams's Trading History
Ardelyx
Aug 25, 2026
Chief Patient Officer
Informative Sell
41.35K
$1.39M
Enliven Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Laura A Williams's performance on stock
You May Also Like
Laura A Williams insider profile FAQ
What is the percentage of profitable transactions made by Laura A Williams?
The percentage of profitable transactions made by Laura A Williams is 47%.
What is the average return per transaction made by Laura A Williams?
The average return per transaction made by Laura A Williams is -30.30%.
What stocks does Laura A Williams hold?
Laura A Williams holds: ARDX, ELVN stocks.
What was Laura A Williams’s latest transaction?
Laura A Williams latest transaction was an Informative Sell of $41.35K.
What was Laura A Williams's most profitable transaction?
Laura A Williams’s most profitable transaction was an Informative Sell of ARDX stock on January 9, 2026. The return on the trade was 51.10%.
What is Laura A Williams's role in Ardelyx?
Laura A Williams's role in Ardelyx is Chief Patient Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.